Skip to content

Depression: all studies

Page 635 of 1,034: studies 6,341 to 6,350 of 10,336, newest first. Back to the depression overview

Research

A clinical research perspective on the regulation of medical and non‐medical use of psychedelic drugs

Addiction August 12, 2024 Michael P. Bogenschutz 1 citation

Recent experience with off-label use of ketamine and recent challenges experienced in research with MDMA and psilocybin provide additional perspectives on how best to continue development of experimental psychedelic medications. Andrews et al. [1] provide a valuable perspective by noting the parallels between the ongoing deregulation of cannabis and what is now happening with psychedelics. The...

DOI: 10.1111/add.16647 (opens in new tab) Psilocybin MDMA Parallels Perspective graphical +2

Brain region-specific action of ketamine as a rapid antidepressant.

Science August 9, 2024 Min Chen, Shuangshuang Ma, Hanxiao Liu et al. 87 citations

Ketamine has been found to have rapid and potent antidepressant activity. However, despite the ubiquitous brain expression of its molecular target, the N-methyl-d-aspartate receptor (NMDAR), it was not clear whether there is a selective, primary site for ketamine's antidepressant action. We found that ketamine injection in depressive-like mice specifically blocks NMDARs in lateral habenular...

DOI: 10.1126/science.ado7010 (opens in new tab) Full text (opens in new tab) Depression treatment Ketamine therapy Brain research Psychopharmacology

Drugie życie psychodelików

Kosmos August 8, 2024 Krystyna Gołembiowska, K. Kamińska

Psychedelics known for mankind from millennia are class of compounds that alter consciousness, affect perception and produce hallucinations. Classic psychedelics such as psilocybin, mescaline, dimethyltryptamine (DMT) and lysergic acid diethylamide (LSD) have pharmacodynamic serotonergic effects. They are known to exert profound effects on neuroplasticity i.e. alteration of neuronal structure...

Czy psychodeliki staną się lekami?

Kosmos August 8, 2024 Maciej Lorenc

In the past decade, there has been a surge of interest in the therapeutic use of psychedelics, especially in the treatment of depression and addiction, resulting in many new research projects on their properties. This publication outlines the history of scientific experiments conducted with psychedelics in the 1950s and 1960s, as well as their subsequent international outlawing in the 1970s and...

Innovative Ketamine Formulations: Enhancing Therapeutic Efficacy and Safety.

ACS Medicinal Chemistry Letters August 8, 2024 Robert B. Kargbo 1 citation

Ketamine, originally developed as an anesthetic, has shown significant potential for treating depression, chronic pain, and other conditions. However, its conventional formulations often result in side effects such as hallucinations and dizziness due to rapid spikes in blood concentration. This article explores recent patents that optimize ketamine delivery and efficacy: subcutaneous injectable...

DOI: 10.1021/acsmedchemlett.4c00330 (opens in new tab) Full text (opens in new tab) Ketamine-therapy Drug-delivery-systems Pharmaceutical-innovation Depression-treatment

Mindfulness, teacher mental health, and well-being in early education: a correlational study.

BMC Psychology August 6, 2024 Carolina Corthorn, Víctor Pedrero, Natalia Torres et al. 16 citations

This study analyzed the relationship between mindfulness and variables considered relevant for teacher-student interactions: teacher burnout, general stress, anxiety, depression, and quality of life. We hypothesized that mindfulness would relate negatively with mental health variables and positively with quality of life. We also explored which specific aspects of mindfulness would predict...

Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money

Annual Review of Psychology August 2, 2024 Keith Humphreys, Daniel Stjepanović, Wayne Hall et al. 18 citations

Therapeutic claims about many psychedelic drugs have not been evaluated in any studies of even modest rigor. The science of psychedelic drugs is strengthening, however, making it easier to differentiate some promising findings amid the hype that suffuses this research area. Ketamine has risks of adverse side effects (e.g., addiction and cystitis), but multiple studies suggest it can benefit...

Measuring Decentering – Development and Validation of the French Version of the Experiences Questionnaire (EQ-F)

Psychological Test Adaptation and Development August 1, 2024 Liudmila Gamaiunova, Rebecca Shankland, Michael Moore et al. 1 citation

Abstract: This article presents the results of a psychometric evaluation and initial validation of the French version of the Experiences Questionnaire (EQ-F), a self-report measure of decentering. Decentering is the ability to maintain a detached stance toward one’s thoughts and emotions and is related to adaptive psychological functioning. Study 1 explored the EQ-F’s factor structure and...

The effectiveness of taught, self-help mindfulness-based interventions on Chinese adolescents' well-being, mental health, prosocial and difficult behavior, and coping strategy.

Applied Psychology: Health and Well-Being August 1, 2024 Wanying Zhou, Ros Mclellan 13 citations

Despite China's enduring historical connection with mindfulness and the growing recognition of mindfulness-based interventions (MBIs) in Western education, mindfulness remains relatively underexplored in the Chinese education system. This study addresses the scarcity of resources and certified instructors in China by assessing the effectiveness of MBIs in both taught and self-help forms in...

DOI: 10.1111/aphw.12517 (opens in new tab) Full text (opens in new tab) Mindfulness Chinese schools Adolescents Prosocial behavior +2

The effect of mindfulness-based interventions on mental health outcomes and wellbeing of informal caregivers of people with mental illness: A systematic review and meta-analysis.

International Journal of Mental Health Nursing August 1, 2024 Xiaofeng Zhang, Huilin Ren, Caixia Wang et al. 8 citations

The increasing prevalence of mental illness has resulted in a growing burden on informal caregivers. Mindfulness-based interventions, as a form of psychotherapy, have shown efficacy in alleviating psychological stress and enhancing emotional and physical well-being. However, the utilisation of mindfulness-based interventions for informal caregivers of individuals with mental illness remains...

DOI: 10.1111/inm.13295 (opens in new tab) Full text (opens in new tab) Mindfulness Informal caregivers Mental health Mental illness +1